Logo image of 1ANTM.MI

ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis

BIT:1ANTM - Euronext Milan - US0367521038 - Common Stock - Currency: EUR

246  +5.4 (+2.24%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to 1ANTM. 1ANTM was compared to 25 industry peers in the Health Care Providers & Services industry. 1ANTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ANTM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year 1ANTM was profitable.
In the past year 1ANTM had a positive cash flow from operations.
In the past 5 years 1ANTM has always been profitable.
In the past 5 years 1ANTM always reported a positive cash flow from operatings.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

1ANTM's Return On Assets of 4.40% is fine compared to the rest of the industry. 1ANTM outperforms 74.07% of its industry peers.
1ANTM has a Return On Equity of 12.26%. This is in the better half of the industry: 1ANTM outperforms 70.37% of its industry peers.
1ANTM has a better Return On Invested Capital (5.90%) than 62.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ANTM is in line with the industry average of 5.74%.
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROIC 5.9%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of 1ANTM (2.83%) is comparable to the rest of the industry.
1ANTM's Profit Margin has declined in the last couple of years.
1ANTM's Operating Margin of 4.60% is in line compared to the rest of the industry. 1ANTM outperforms 48.15% of its industry peers.
In the last couple of years the Operating Margin of 1ANTM has declined.
Industry RankSector Rank
OM 4.6%
PM (TTM) 2.83%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ANTM is destroying value.
1ANTM has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1ANTM has less shares outstanding
1ANTM has a worse debt/assets ratio than last year.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of 1ANTM is 5.70, which is a neutral value as it means it would take 1ANTM, 5.70 years of fcf income to pay off all of its debts.
1ANTM has a Debt to FCF ratio of 5.70. This is in the better half of the industry: 1ANTM outperforms 74.07% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that 1ANTM is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.65, 1ANTM is doing good in the industry, outperforming 70.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Altman-Z N/A
ROIC/WACC0.78
WACC7.59%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

6

3. Growth

3.1 Past

1ANTM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.64%.
1ANTM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.17% yearly.
Looking at the last year, 1ANTM shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
1ANTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%

3.2 Future

Based on estimates for the next years, 1ANTM will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.57% on average per year.
Based on estimates for the next years, 1ANTM will show a quite strong growth in Revenue. The Revenue will grow by 8.96% on average per year.
EPS Next Y5.39%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
EPS Next 5Y12.57%
Revenue Next Year12.17%
Revenue Next 2Y8.92%
Revenue Next 3Y8.04%
Revenue Next 5Y8.96%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B 250B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.50, which indicates a very decent valuation of 1ANTM.
Based on the Price/Earnings ratio, 1ANTM is valued cheaper than 92.59% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1ANTM to the average of the S&P500 Index (26.48), we can say 1ANTM is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.07, the valuation of 1ANTM can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ANTM indicates a rather cheap valuation: 1ANTM is cheaper than 92.59% of the companies listed in the same industry.
1ANTM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE 8.5
Fwd PE 7.07
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1ANTM.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ANTM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 11.94
EV/EBITDA 8.29
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.58
PEG (5Y)0.76
EPS Next 2Y9.72%
EPS Next 3Y11.61%

More info and screens

5

5. Dividend

5.1 Amount

1ANTM has a Yearly Dividend Yield of 2.42%.
Compared to an average industry Dividend Yield of 2.85, 1ANTM pays a bit more dividend than its industry peers.
1ANTM's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

28.40% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

More info and screens

ELEVANCE HEALTH INC

BIT:1ANTM (7/25/2025, 7:00:00 PM)

246

+5.4 (+2.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-15 2025-10-15/amc
Inst Owners92.69%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap55.39B
Analysts79.29
Price Target419.89 (70.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend5.74
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-13.09%
PT rev (3m)-13.09%
EPS NQ rev (1m)-42.57%
EPS NQ rev (3m)-42.57%
EPS NY rev (1m)0.54%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)0.5%
Revenue NY rev (1m)1.8%
Revenue NY rev (3m)1.8%
Valuation
Industry RankSector Rank
PE 8.5
Fwd PE 7.07
P/S 0.33
P/FCF 11.94
P/OCF 9.86
P/B 1.44
P/tB 16.35
EV/EBITDA 8.29
EPS(TTM)28.95
EY11.77%
EPS(NY)34.8
Fwd EY14.15%
FCF(TTM)20.61
FCFY8.38%
OCF(TTM)24.96
OCFY10.15%
SpS736.98
BVpS170.26
TBVpS15.05
PEG (NY)1.58
PEG (5Y)0.76
Profitability
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROCE 7.72%
ROIC 5.9%
ROICexc 6.38%
ROICexgc 11.77%
OM 4.6%
PM (TTM) 2.83%
GM N/A
FCFM 2.8%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Debt/EBITDA 2.8
Cap/Depr 75.47%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 62.96%
Profit Quality 98.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.59%
ROIC/WACC0.78
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y5.39%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
EPS Next 5Y12.57%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.17%
Revenue Next 2Y8.92%
Revenue Next 3Y8.04%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year11.18%
EBIT Next 3Y10.33%
EBIT Next 5Y11.33%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%